JACQUELINE MALENFANT: Open Payments
NPI 1881112431 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 51 payments from 8 companies in 2025. Trend: 2023 $332 · 2024 $587 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $298 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $226 |
| Aimmune Therapeutics, Inc. | 14 | $180 |
| Ipsen Biopharmaceuticals, Inc | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Gilead Sciences, Inc. | 4 | $80 |
| Madrigal Pharmaceuticals | 2 | $36 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: XIFAXAN, VOWST, SKYRIZI, IQIRVO, ENTYVIO, ZENPEP, RINVOQ, LINZESS.
Industry payments across OH — which companies pay providers there.
